NS-050/NCNP-03

N/A

Report date: 2024/12/27 10:50:26
NME

Base Information

Drug NameNS-050/NCNP-03
Drug Alias NameExon 50 skipping antisense oligonucleotideNS-050/NCNP-03
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionDystrophin expression stimulantsRNA interference
TargetsNot applicable
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSouth Korea +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNs PharmaNs Pharma IncNational Center Of Neurology And Psychiatry, Japan +[4] 
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A